We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Big pharma, big problems

17 December 2004 By Robert Cyran

The US drugs group’s stock has been slammed after its blockbuster painkiller, Celebrex, was linked to heart attacks. This is a bigger blow for the sector than Vioxx. Add a heavy fall in AstraZeneca and it makes one of the worst days ever for big pharma.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)